Suchergebnisse - (Person:"Liu, Peng")

PubPharm (99)

1

Diselenide-Bridged Doxorubicin Dimeric Prodrug : Synthesis and Redox-Triggered Drug Release

enthalten in: Molecules (Basel, Switzerland) | 2024

von Hu, Y. | Liu, P.

2

Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: Annals of hematology | 2024

von Zhong, Q. | Chen, H. | Chen, D. | +11

3

Molecular Design and Controlled Self-Assembly of Copolymers as Core-Shell-Corona Nanoparticles for Smarter Tumor Treatment

enthalten in: Langmuir : the ACS journal of surfaces and colloids | 2024

von Liu, P.

4

Chitotriose Enhanced Antitumor Activity of Doxorubicin through Egr1 Upregulation in MDA-MB-231 Cells

enthalten in: Marine drugs | 2023

von Li, H. | Ji, K. | Liu, P. | +6

5

Formulation of DOX-dimer with bi-functionalized chitooligosaccharide for tumor-specific self-boosted drug release and synergistic chemo/chemodynamic therapy

enthalten in: Carbohydrate polymers | 2023

von Xie, P. | Liu, P.

6

Hybrid Micelles of Carbon Quantum Dot-Doxorubicin Conjugates as Nanotheranostics for Tumor Therapy and Turn-On Fluorescence Imaging : Impact of Conjugated Structures and On-Off-On Mechanism

enthalten in: Molecular pharmaceutics | 2023

von Li, J. | Yang, Y. | Liu, P.

7

Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China : a propensity-score matched multicenter study

enthalten in: Annals of hematology | 2022

von Wang, Y. | Xu, J. | Li, J. | +13

8

A new prognostic model including platelet/lymphocyte ratio and International Prognostic Score 3 for freedom from progression in patients with previously untreated advanced classical Hodgkin lymphoma

enthalten in: Asia-Pacific journal of clinical oncology | 2022

von Tao, Y. | Chen, H. | Zhou, Y. | +10

9

Insights into Aptamer-Drug Delivery Systems against Prostate Cancer

enthalten in: Molecules (Basel, Switzerland) | 2022

von Wang, X. | Zhou, Q. | Li, X. | +5

10

Engineering Chemotherapeutic-Augmented Calcium Phosphate Nanoparticles for Treatment of Intraperitoneal Disseminated Ovarian Cancer

enthalten in: ACS applied materials & interfaces | 2022

von Qiu, M. | Chen, J. | Huang, X. | +8

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]